Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study

BACKGROUND: Patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC) and disease-related poor prognostic factors are not well characterized. We aimed to describe patient demographics, disease characteristics, treatment patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Davie, A., Cuyun Carter, G., Rider, A., Bailey, A., Lewis, K., Price, G., Ostojic, H., Ringeisen, F., Pivot, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358418/
https://www.ncbi.nlm.nih.gov/pubmed/34371379
http://dx.doi.org/10.1016/j.esmoop.2021.100226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358418/
https://www.ncbi.nlm.nih.gov/pubmed/34371379
http://dx.doi.org/10.1016/j.esmoop.2021.100226

Ejemplares similares